Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

60.29%

54.44%

64.90%

Annual Dental Visits (ADV)

50.02%

53.10%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

44.39%

40.69%

46.74%

Appropriate Testing for Pharyngitis (CWP)

76.51%

80.45%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

83.82%

85.17%

93.08%

Asthma Medication Ratio (AMR) Total

66.86%

68.62%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

41.97%

53.55%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

55.96%

44.04%

68.61%

Breast Cancer Screening (BCS)

43.31%

46.13%

55.25%

Cervical Cancer Screening (CCS)

47.19%

50.50%

59.85%

Childhood Immunization Status (CIS) Combination #10

32.12%

32.36%

35.04%

Chlamydia Screening in Women (CHL) Total

57.16%

60.11%

61.07%

Controlling High Blood Pressure (CBP)

47.20%

47.45%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

81.82%

84.06%

80.86%

Eye Exam for Patients With Diabetes (EED)

43.55%

43.31%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

14.78%

27.27%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

31.05%

30.15%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

31.90%

33.02%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

36.64%

43.51%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

49.08%

57.64%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

43.80%

42.34%

55.72%

Immunizations for Adolescents (IMA) Combination #2

33.31%

30.90%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

21.05%

49.85%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

26.72%

26.55%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

33.33%

34.49%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

19.04%

18.13%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

76.52%

73.89%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

85.22%

82.14%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

97.27%

96.41%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.48%

80.29%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

71.29%

73.48%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

NR

24.84%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

3.64%

3.10%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

80.13%

79.57%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

70.26%

65.72%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

66.35%

65.15%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

66.25%

64.09%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

65.91%

66.47%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

64.32%

63.38%

75.44%

Use of Opioids at High Dosage (HDO)

0.90%

0.74%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

2.36%

0.00%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

68.37%

74.70%

83.21%